SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059564
Filing Date
2024-05-14
Accepted
2024-05-14 16:14:40
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bolt-20240331.htm   iXBRL 10-Q 1354087
2 EX-31.1 bolt-ex31_1.htm EX-31.1 12745
3 EX-31.2 bolt-ex31_2.htm EX-31.2 12711
4 EX-32.1 bolt-ex32_1.htm EX-32.1 6517
5 EX-32.2 bolt-ex32_2.htm EX-32.2 7526
  Complete submission text file 0000950170-24-059564.txt   6387744

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20240331.xsd EX-101.SCH 892052
60 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20240331_htm.xml XML 1265332
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39988 | Film No.: 24944516
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)